Omega Healthcare Investors INC

Omega Healthcare Investors announced strong second quarter 2026 results, including $126 million in new investments, an increase in quarterly dividend, and raised full-year Adjusted FFO guidance.

Omega Healthcare Investors successfully concluded its 2026 Annual Meeting, re-electing all director nominees and updating beneficial ownership disclosures.

Omega Healthcare Investors, Inc. has announced significant leadership changes, with CEO C. Taylor Pickett and CFO Robert O. Stephenson retiring, and new appointments for President and CFO.

Omega Healthcare Investors announced robust first quarter 2026 financial results, including significant new investments and an increase in full-year Adjusted FFO guidance.

Omega Healthcare Investors, Inc. announced robust fourth quarter and full year 2025 financial results, marked by significant new investments, debt reduction, and improved operator coverage.

Omega Healthcare Investors, Inc. amended employment agreements for its named executive officers, extending terms and increasing compensation and severance for key leaders.

Omega Healthcare Investors, Inc. (OHI) announced robust financial performance for the second quarter of 2026, driven by increased rental income and strategic acquisitions.

Omega Healthcare Investors, Inc. reported increased revenues and net income for the first quarter of 2026, driven by acquisitions and improved rental income, while managing operational challenges.

Omega Healthcare Investors, Inc. reported significant revenue and earnings growth for Q3 and the first nine months of 2025, driven by acquisitions and effective capital management, despite ongoing operator challenges and regulatory uncertainties.

Omega Healthcare Investors, a leading healthcare REIT, announced significant revenue and net income growth for Q2 2025, driven by strategic acquisitions and effective capital management, despite ongoing challenges with certain operators and increased regulatory scrutiny.

Omega Healthcare Investors announces its Q1 2025 financial results, highlighting strategic investments, dispositions, and ongoing efforts to manage operator collectibility issues amid a recovering healthcare landscape.

Omega Healthcare Investors reported its Q3 2024 results, highlighting increased revenues and strategic acquisitions, while also addressing ongoing operator challenges and restructuring efforts.

Omega Healthcare Investors, Inc. reported a significant increase in net income and FFO for 2025, driven by strategic acquisitions and lease escalations, despite ongoing operator challenges.

Omega Healthcare Investors reports a solid financial performance for 2024 while strategically addressing operator challenges and regulatory shifts in the long-term care industry.

Omega Healthcare Investors' 2023 annual report reveals strategic portfolio adjustments amidst ongoing healthcare industry headwinds.

Omega Healthcare Investors reports on Chief Financial Officer Robert O. Stephenson's acquisition of Profits Interest Units and Operating Partnership Units.

C. Taylor Pickett, CEO of Omega Healthcare Investors, reports changes in beneficial ownership of company securities, including vested Profits Interest Units and OP Units.

Gail D. Makode, Chief Legal Officer of Omega Healthcare Investors Inc., reported the vesting of Profits Interest Units into Operating Partnership Units on June 30, 2026.

Vikas Gupta, Chief Investment Officer at Omega Healthcare Investors, reports on the vesting of Profits Interest Units into Operating Partnership Units.

Matthew P. Gourmand of Omega Healthcare Investors reports on the vesting of Profits Interest Units into Operating Partnership Units, impacting beneficial ownership.

Neal Ballew, Chief Accounting Officer at Omega Healthcare Investors Inc., reported transactions involving common stock purchases and sales related to employee stock plans and tax withholding.

Omega Healthcare Investors announces its 2026 Annual Meeting of Stockholders, scheduled for June 5, 2026, to elect directors, ratify auditor selection, and vote on executive compensation.

Omega Healthcare Investors clarifies that the New York Stock Exchange considers the proposal to increase the number of authorized shares of common stock a 'routine' matter eligible for discretionary voting by brokers.

Omega Healthcare Investors is set to convene its 2025 Annual Meeting of Stockholders on June 6, 2025, featuring proposals including director elections, auditor ratification, executive compensation advisory vote, and a charter amendment to increase authorized common stock shares.

Omega Healthcare Investors announces its 2024 Annual Meeting and provides details on voting procedures and proposals.

Omega Healthcare Investors' proxy statement details the upcoming annual meeting, director nominations, executive compensation, and corporate governance practices.

Vanguard Capital Management has disclosed a beneficial ownership of 5.3% in Omega Healthcare Investors Inc. common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a 9.18% beneficial ownership in Omega Healthcare Investors Inc. as of March 31, 2026.

The Vanguard Group reports 0% beneficial ownership of Omega Healthcare Investors Inc. common stock following an internal realignment.

Cohen & Steers, Inc. and its affiliates reported a 4.64% beneficial ownership stake in Omega Healthcare Investors, Inc. common stock as of December 31, 2025.

Cohen & Steers, Inc. and its affiliates reported a 4.64% beneficial ownership stake in Omega Healthcare Investors, Inc. as of December 31, 2025.

Cohen & Steers, Inc. and its affiliates reported a passive beneficial ownership of 5.92% in Omega Healthcare Investors, Inc. common stock as of September 30, 2025.